This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignee: Novartis Ag. Active years: 2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010
Title: Jan E De Vries: Innovator in Monoclonal Antibodies
Introduction
Jan E De Vries is a prominent inventor based in Vienna, Austria. He has made significant contributions to the field of biotechnology, particularly in the development of human monoclonal antibodies. His work focuses on addressing diseases mediated by interleukin-4 and immunoglobulin E.
Latest Patents
Jan E De Vries holds a patent for "Human monoclonal antibodies against human IL-4." This patent involves antibodies that are specific for human interleukin-4 and their application in treating IL-4 and/or IgE mediated diseases. He has 1 patent to his name, showcasing his innovative approach to medical science.
Career Highlights
Jan E De Vries is associated with Novartis AG, a leading global healthcare company. His role at Novartis has allowed him to work on groundbreaking research and development projects that aim to improve patient outcomes through advanced therapeutic solutions.
Collaborations
Throughout his career, Jan has collaborated with notable professionals in the field, including José M Carballido Herrera and Christoph Schwaerzler. These collaborations have further enhanced the impact of his research and innovations.
Conclusion
Jan E De Vries is a key figure in the development of monoclonal antibodies, contributing to advancements in the treatment of specific diseases. His work continues to influence the biotechnology landscape, making a lasting impact on healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile